Activatable cell penetrating peptide-peptide nucleic acid conjugate via reduction of azobenzene PEG chains

Journal of the American Chemical Society

Volumn 136, Issue 37, 2014, Pages 12868-12871

  Lee, Soo Hyeon ^a   Moroz, Elena ^a   Castagner, Bastien ^a   Leroux, Jean Christophe ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; AZOBENZENE; BIOMOLECULES; CONTROLLED DRUG DELIVERY; DIAGNOSIS; PEPTIDES; TARGETED DRUG DELIVERY;

ACTIVATABLE CELL PENETRATING PEPTIDES; ADENOCARCINOMA CELLS; ATTRACTIVE STRATEGIES; BIOACTIVE MOLECULES; NUCLEIC ACID ANALOGUES; PEPTIDE NUCLEIC ACID; STIMULI-RESPONSIVE; TRANSFECTION ACTIVITY;

NUCLEIC ACIDS;

AZO REDUCTASE; AZOBENZENE; CELL PENETRATING PEPTIDE; NANOCARRIER; PEPTIDE NUCLEIC ACID; AZO COMPOUND; MACROGOL DERIVATIVE;

ARTICLE; COLON ADENOCARCINOMA; COLON DISEASE; COLON MUCOSA; COLORECTAL CANCER CELL LINE; CONJUGATE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; GENETIC TRANSFECTION; IN VITRO STUDY; AMINO ACID SEQUENCE; CHEMISTRY; COLON; CYTOLOGY; GENE SILENCING; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; OXIDATION REDUCTION REACTION; TUMOR CELL LINE;

AMINO ACID SEQUENCE; AZO COMPOUNDS; CELL LINE, TUMOR; CELL-PENETRATING PEPTIDES; COLON; GENE SILENCING; HUMANS; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PEPTIDE NUCLEIC ACIDS; POLYETHYLENE GLYCOLS; TRANSFECTION;

EID: 84921466125     PISSN: 00027863     EISSN: 15205126     Source Type: Journal    
DOI: 10.1021/ja507547w     Document Type: Article

References (37)

1. (a) Lee, S. H.; Castagner, B.; Leroux, J. C. Eur. J. Pharm. Biopharm. 2013, 85, 5.
2. (b) Mae, M.; Andaloussi, S. E.; Lehto, T.; Langel, U. Expert Opin. Drug Delivery 2009, 6, 1195.
3. (c) Heitz, F.; Morris, M. C.; Divita, G. Br. J. Pharmacol. 2009, 157, 195.
4. (a) Teesalu, T.; Sugahara, K. N.; Kotamraju, V. R.; Ruoslahti, E. Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 16157.
5. (b) Kumar, P.; Wu, H.; McBride, J. L.; Jung, K. E.; Kim, M. H.; Davidson, B. L.; Lee, S. K.; Shankar, P.; Manjunath, N. Nature 2007, 448, 39.
6. (a) Kale, A. A.; Torchilin, V. P. J. Liposome Res. 2007, 17, 197.
7. (b) Mok, H.; Bae, K. H.; Ahn, C. H.; Park, T. G. Langmuir 2009, 25, 1645.
8. (c) Hansen, M. B.; van Gaal, E.; Minten, I.; Storm, G.; van Hest, J. C.; Lowik, D. W. J. Controlled Release 2012, 164, 87.
9. (d) Jiang, T.; Olson, E. S.; Nguyen, Q. T.; Roy, M.; Jennings, P. A.; Tsien, R. Y. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 17867.
10. (e) Weinstain, R.; Savariar, E. N.; Felsen, C. N.; Tsien, R. Y. J. Am. Chem. Soc. 2014, 136, 874.
11. Van den Mooter, G.; Maris, B.; Samyn, C.; Augustijns, P.; Kinget, R. J. Pharm. Sci. 1997, 86, 1321.
12. (a) Jeffrey, S. C.; Torgov, M. Y.; Andreyka, J. B.; Boddington, L.; Cerveny, C. G.; Denny, W. A.; Gordon, K. A.; Gustin, D.; Haugen, J.; Kline, T.; Nguyen, M. T.; Senter, P. D. J. Med. Chem. 2005, 48, 1344.
13. (b) Bildstein, L.; Dubernet, C.; Couvreur, P. Adv. Drug Delivery Rev. 2011, 63, 3.
14. Houba, P. H.; Boven, E.; Erkelens, C. A.; Leenders, R. G.; Scheeren, J. W.; Pinedo, H. M.; Haisma, H. J. Br. J. Cancer 1998, 78, 1600.
15. Dean, D. A. Adv. Drug Delivery Rev. 2000, 44, 81.
16. Belousov, E. S.; Afonina, I. A.; Kutyavin, I. V.; Gall, A. A.; Reed, M. W.; Gamper, H. B.; Wydro, R. M.; Meyer, R. B. Nucleic Acids Res. 1998, 26, 1324.
17. Turner, J. J.; Ivanova, G. D.; Verbeure, B.; Williams, D.; Arzumanov, A. A.; Abes, S.; Lebleu, B.; Gait, M. J. Nucleic Acids Res. 2005, 33, 6837.
18. Maier, M. A.; Esau, C. C.; Siwkowski, A. M.; Wancewicz, E. V.; Albertshofer, K.; Kinberger, G. A.; Kadaba, N. S.; Watanabe, T.; Manoharan, M.; Bennett, C. F.; Griffey, R. H.; Swayze, E. E. J. Med. Chem. 2006, 49, 2534.
19. Abes, S.; Turner, J. J.; Ivanova, G. D.; Owen, D.; Williams, D.; Arzumanov, A.; Clair, P.; Gait, M. J.; Lebleu, B. Nucleic Acids Res. 2007, 35, 4495.
20. El-Andaloussi, S.; Johansson, H. J.; Holm, T.; Langel, U. Mol. Ther. 2007, 15, 1820.
21. Rozema, D. B.; Ekena, K.; Lewis, D. L.; Loomis, A. G.; Wolff, J. A. Bioconjugate Chem. 2003, 14, 51.
22. Rittner, K.; Benavente, A.; Bompard-Sorlet, A.; Heitz, F.; Divita, G.; Brasseur, R.; Jacobs, E. Mol. Ther. 2002, 5, 104.
23. Simeoni, F.; Morris, M. C.; Heitz, F.; Divita, G. Nucleic Acids Res. 2003, 31, 2717.
24. Morris, M. C.; Gros, E.; Aldrian-Herrada, G.; Choob, M.; Archdeacon, J.; Heitz, F.; Divita, G. Nucleic Acids Res. 2007, 35, e49.
25. 17Lundberg, P.; El-Andaloussi, S.; Sutlu, T.; Johansson, H.; Langel, U. FASEB J. 2007, 21, 2664.
26. Wyman, T. B.; Nicol, F.; Zelphati, O.; Scaria, P. V.; Plank, C.; Szoka, F. C., Jr. Biochemistry 1997, 36, 3008.
27. Lundin, P.; Johansson, H.; Guterstam, P.; Holm, T.; Hansen, M.; Langel, U.; Andaloussi S, E. L. Bioconjugate Chem. 2008, 19, 2535.
28. Sugita, T.; Yoshikawa, T.; Mukai, Y.; Yamanada, N.; Imai, S.; Nagano, K.; Yoshida, Y.; Shibata, H.; Yoshioka, Y.; Nakagawa, S.; Kamada, H.; Tsunoda, S. I.; Tsutsumi, Y. Br. J. Pharmacol. 2008, 153, 1143.
29. El-Andaloussi, S.; Jarver, P.; Johansson, H. J.; Langel, U. Biochem. J. 2007, 407, 285.
30. (a) Cho, E. C.; Zhang, Q.; Xia, Y. Nat. Nanotechnol. 2011, 6, 385.
31. (b) Giger, E. V.; Castagner, B.; Räikkönen, J.; Mönkkönen, J.; Leroux, J.-C. Adv. Healthcare Mater. 2013, 2, 134.
32. Rao, J.; Khan, A. J. Am. Chem. Soc. 2013, 135, 14056.
33. Merino, E. Chem. Soc. Rev. 2011, 40, 3835.
34. (a) Li, X.; Li, J.; Gao, Y.; Kuang, Y.; Shi, J.; Xu, B. J. Am. Chem. Soc. 2010, 132, 17707.
35. (b) Leriche, G.; Budin, G.; Brino, L.; Wagner, A. Eur. J. Org. Chem. 2010, 2010, 4360.
36. (c) Yang, Y. Y.; Grammel, M.; Raghavan, A. S.; Charron, G.; Hang, H. C. Chem. Biol. 2010, 17, 1212.
37. (d) Denny, J. B.; Blobel, G. Proc. Natl. Acad. Sci. U.S.A. 1984, 81, 5286.